Gaucher Disease Type 3 clinical trials

Explore recruiting gaucher disease type 3 clinical trials.

Recruiting gaucher disease type 3 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gaucher Disease Type 3 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effectiveness of ambroxol in children and adults with Gaucher disease 3: n-of-1 series

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 4-part, open-label, multicenter, multinational study of the safety, tolerability, pharmacokinetics, pharmacodynamic, and exploratory efficacy of venglustat in combination with Cerezyme in adult patients with Gaucher disease Type 3 with venglustat monotherapy extension

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

LEAP2MONO - EFC17215 A phase 3, multicenter, multinational, randomized, double-blind, double-dummy, active-comparator study to evaluate the efficacy and safety of venglustat in adult and pediatric patients with Gaucher disease Type 3 (GD3) who have reached therapeutic goals with Enzyme Replacement Therapy (ERT)

Germany, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Gaucher Disease Type 3 trials by city

Gaucher Disease Type 3 in Toronto Gaucher Disease Type 3 in Vancouver Gaucher Disease Type 3 in Montreal Gaucher Disease Type 3 in Calgary Gaucher Disease Type 3 in Edmonton Gaucher Disease Type 3 in Ottawa Gaucher Disease Type 3 in Winnipeg Gaucher Disease Type 3 in Quebec City Gaucher Disease Type 3 in Hamilton Gaucher Disease Type 3 in Kitchener Gaucher Disease Type 3 in London Gaucher Disease Type 3 in Halifax Gaucher Disease Type 3 in New York Gaucher Disease Type 3 in Los Angeles Gaucher Disease Type 3 in Chicago Gaucher Disease Type 3 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease